Johan Törlén

452 total citations
16 papers, 307 citations indexed

About

Johan Törlén is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Johan Törlén has authored 16 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Johan Törlén's work include Hematopoietic Stem Cell Transplantation (13 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (5 papers). Johan Törlén is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (5 papers). Johan Törlén collaborates with scholars based in Sweden, Canada and United States. Johan Törlén's co-authors include Jonas Mattsson, Mats Remberger, Olle Ringdén, Michael Uhlin, Per Ljungman, Mats Engström, Emma Watz, Jacek Winiarski, Karin Garming-Legert and Berit Sundberg and has published in prestigious journals such as Frontiers in Immunology, Supportive Care in Cancer and Haematologica.

In The Last Decade

Johan Törlén

16 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Törlén Sweden 10 224 115 76 48 46 16 307
Søren Lykke Petersen Denmark 9 180 0.8× 146 1.3× 65 0.9× 25 0.5× 45 1.0× 33 305
A. Birgitta Versluijs Netherlands 8 197 0.9× 96 0.8× 60 0.8× 54 1.1× 38 0.8× 10 257
Mark Vander Lugt United States 6 294 1.3× 171 1.5× 60 0.8× 38 0.8× 28 0.6× 14 380
Geothy Chakupurakal Germany 12 156 0.7× 157 1.4× 126 1.7× 44 0.9× 31 0.7× 28 369
Lisa Cook United States 10 160 0.7× 107 0.9× 95 1.3× 29 0.6× 56 1.2× 30 304
Kazuo Hatanaka Japan 10 157 0.7× 51 0.4× 77 1.0× 43 0.9× 31 0.7× 33 264
Ayad Ahmed Hussein Jordan 10 157 0.7× 73 0.6× 38 0.5× 46 1.0× 40 0.9× 25 236
M. Schaffer Sweden 6 238 1.1× 159 1.4× 63 0.8× 40 0.8× 28 0.6× 8 335
Irene García‐Cadenas Spain 11 270 1.2× 84 0.7× 198 2.6× 60 1.3× 94 2.0× 45 407
Ioannis Politikos United States 8 173 0.8× 61 0.5× 101 1.3× 34 0.7× 21 0.5× 30 278

Countries citing papers authored by Johan Törlén

Since Specialization
Citations

This map shows the geographic impact of Johan Törlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Törlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Törlén more than expected).

Fields of papers citing papers by Johan Törlén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Törlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Törlén. The network helps show where Johan Törlén may publish in the future.

Co-authorship network of co-authors of Johan Törlén

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Törlén. A scholar is included among the top collaborators of Johan Törlén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Törlén. Johan Törlén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Dahllöf, Göran, Johan Törlén, Alessandra Majorana, et al.. (2023). Incidence, severity, and temporal development of oral complications in pediatric allogeneic hematopoietic stem cell transplant patients – a multicenter study. Supportive Care in Cancer. 31(12). 702–702. 2 indexed citations
3.
Ringdén, Olle, et al.. (2021). Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care. International Journal of Hematology. 113(5). 712–722. 3 indexed citations
4.
Legert, Karin Garming, Olle Ringdén, Mats Remberger, et al.. (2020). Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis. Oral Diseases. 27(5). 1217–1225. 7 indexed citations
5.
Törlén, Johan, Ahmed Gaballa, Mats Remberger, et al.. (2019). Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(6). 1260–1268. 20 indexed citations
6.
Sundin, Mikael, Johan Törlén, Sarah Thunberg, et al.. (2019). Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion. Frontiers in Immunology. 10. 189–189. 14 indexed citations
7.
El‐Serafi, Ibrahim, Mats Remberger, Olle Ringdén, et al.. (2019). Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan‐Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation. Clinical and Translational Science. 13(2). 293–300. 10 indexed citations
8.
Törlén, Johan, Mats Remberger, Katarina Le Blanc, Per Ljungman, & Jonas Mattsson. (2017). Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions. Biology of Blood and Marrow Transplantation. 23(4). 677–683. 12 indexed citations
9.
Remberger, Mats, Johan Törlén, Ibrahim El‐Serafi, et al.. (2017). Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation. International Journal of Hematology. 106(4). 471–475. 8 indexed citations
10.
Stikvoort, Arwen, Johan Törlén, Tadepally Lakshmikanth, et al.. (2017). Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease. Frontiers in Immunology. 8. 717–717. 26 indexed citations
11.
Törlén, Johan, Olle Ringdén, Karin Garming-Legert, et al.. (2016). A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation. Haematologica. 101(11). 1417–1425. 49 indexed citations
12.
Blennow, Ola, Mats Remberger, Johan Törlén, et al.. (2016). Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(9). 1684–1689. 12 indexed citations
13.
Remberger, Mats, Johan Törlén, Olle Ringdén, et al.. (2015). Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(5). 889–893. 80 indexed citations
14.
Allard, Annika, et al.. (2015). Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients. Transplant Infectious Disease. 17(6). 785–794. 15 indexed citations
15.
Törlén, Johan, Olle Ringdén, Jennifer Le Rademacher, et al.. (2014). Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 20(9). 1418–1425. 34 indexed citations
16.
Ringdén, Olle, Mats Remberger, Johan Törlén, et al.. (2014). Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital. Pediatric Transplantation. 18(4). 398–404. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026